Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters

Beth A. Beidleman, Charles S. Fulco, Stephen R. Muza, Paul B. Rock, Janet E. Staab, Vincent A. Forte, Michael D. Brothers, Allen Cymerman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Beidleman, Beth A., Charles S. Fulco, Stephen R. Muza, Paul R. Rock, Janet E. Staab, Vincent A. Forte, Michael D. Brothers, and Allen Cymerman. Effect of six days of staging on physiological adjustments and acute mountain sickness during ascent to 4300 meters. High Alt. Med. Biol. 10:253-260, 2009.-This study determined the effectiveness of 6 days (d) of staging at 2200m on physiologic adjustments and acute mountain sickness (AMS) during rapid, high-risk ascent to 4300m. Eleven sea-level (SL) resident men (means±SD; 21±3yr; 78±13kg) completed resting measures of end-tidal CO2 (Petco2), arterial oxygen saturation (Sao2), heart rate (HR), and mean arterial pressure (MAP) at SL and within 1h of exposure to 4300m in a hypobaric chamber prior to 6d of staging at 2200m (preSTG) and on the summit of Pikes Peak following 6d of staging at 2200m (postSTG). Immediately following resting ventilation measures, all performed submaximal exercise (∼55% of altitude-specific maximal oxygen uptake) for ∼2h on a bicycle ergometer to induce higher levels of AMS. AMS-C, calculated from the Environmental Symptoms Questionnaire, was measured following 4h and 8h of exposure at preSTG and postSTG, and the mean was calculated. Resting Petco 2 (mmHg) was unchanged from SL (39.8±2.6) to preSTG (39.3±3.0), but decreased (p<0.05) from preSTG to postSTG (32.8±2.6). Resting Sao2 (%) decreased (p<0.05) from SL (97±2) to preSTG (80±4) and increased (p<0.05) from preSTG to postSTG (83±3). Resting HR (bpm) and MAP (mmHg) did not change in any of the test conditions. The incidence and severity of AMS-C decreased (p<0.05) from preSTG (91±30%; 1.05±0.56) to postSTG (45±53%; 0.59±0.43), respectively. These results suggest that modest physiologic adjustments induced by staging for 6d at 2200m reduced the incidence and severity of AMS during rapid, high-risk ascent to 4300m.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalHigh Altitude Medicine and Biology
Volume10
Issue number3
DOIs
StatePublished - 1 Sep 2009

Fingerprint

Altitude Sickness
Social Adjustment
Oceans and Seas
Arterial Pressure
Heart Rate
Esocidae
Oxygen
Incidence
Ventilation
Siblings
Exercise

Keywords

  • Arterial oxygen saturation
  • Heart rate
  • Hypobaric hypoxia
  • Mean arterial pressure
  • Resting ventilation

Cite this

Beidleman, Beth A. ; Fulco, Charles S. ; Muza, Stephen R. ; Rock, Paul B. ; Staab, Janet E. ; Forte, Vincent A. ; Brothers, Michael D. ; Cymerman, Allen. / Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters. In: High Altitude Medicine and Biology. 2009 ; Vol. 10, No. 3. pp. 253-260.
@article{83cd1e91d854404a8805981a5e2a4a5b,
title = "Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters",
abstract = "Beidleman, Beth A., Charles S. Fulco, Stephen R. Muza, Paul R. Rock, Janet E. Staab, Vincent A. Forte, Michael D. Brothers, and Allen Cymerman. Effect of six days of staging on physiological adjustments and acute mountain sickness during ascent to 4300 meters. High Alt. Med. Biol. 10:253-260, 2009.-This study determined the effectiveness of 6 days (d) of staging at 2200m on physiologic adjustments and acute mountain sickness (AMS) during rapid, high-risk ascent to 4300m. Eleven sea-level (SL) resident men (means±SD; 21±3yr; 78±13kg) completed resting measures of end-tidal CO2 (Petco2), arterial oxygen saturation (Sao2), heart rate (HR), and mean arterial pressure (MAP) at SL and within 1h of exposure to 4300m in a hypobaric chamber prior to 6d of staging at 2200m (preSTG) and on the summit of Pikes Peak following 6d of staging at 2200m (postSTG). Immediately following resting ventilation measures, all performed submaximal exercise (∼55{\%} of altitude-specific maximal oxygen uptake) for ∼2h on a bicycle ergometer to induce higher levels of AMS. AMS-C, calculated from the Environmental Symptoms Questionnaire, was measured following 4h and 8h of exposure at preSTG and postSTG, and the mean was calculated. Resting Petco 2 (mmHg) was unchanged from SL (39.8±2.6) to preSTG (39.3±3.0), but decreased (p<0.05) from preSTG to postSTG (32.8±2.6). Resting Sao2 ({\%}) decreased (p<0.05) from SL (97±2) to preSTG (80±4) and increased (p<0.05) from preSTG to postSTG (83±3). Resting HR (bpm) and MAP (mmHg) did not change in any of the test conditions. The incidence and severity of AMS-C decreased (p<0.05) from preSTG (91±30{\%}; 1.05±0.56) to postSTG (45±53{\%}; 0.59±0.43), respectively. These results suggest that modest physiologic adjustments induced by staging for 6d at 2200m reduced the incidence and severity of AMS during rapid, high-risk ascent to 4300m.",
keywords = "Arterial oxygen saturation, Heart rate, Hypobaric hypoxia, Mean arterial pressure, Resting ventilation",
author = "Beidleman, {Beth A.} and Fulco, {Charles S.} and Muza, {Stephen R.} and Rock, {Paul B.} and Staab, {Janet E.} and Forte, {Vincent A.} and Brothers, {Michael D.} and Allen Cymerman",
year = "2009",
month = "9",
day = "1",
doi = "10.1089/ham.2009.1004",
language = "English",
volume = "10",
pages = "253--260",
journal = "High Altitude Medicine and Biology",
issn = "1527-0297",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters. / Beidleman, Beth A.; Fulco, Charles S.; Muza, Stephen R.; Rock, Paul B.; Staab, Janet E.; Forte, Vincent A.; Brothers, Michael D.; Cymerman, Allen.

In: High Altitude Medicine and Biology, Vol. 10, No. 3, 01.09.2009, p. 253-260.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of six days of staging on physiologic adjustments and acute mountain sickness during ascent to 4300 meters

AU - Beidleman, Beth A.

AU - Fulco, Charles S.

AU - Muza, Stephen R.

AU - Rock, Paul B.

AU - Staab, Janet E.

AU - Forte, Vincent A.

AU - Brothers, Michael D.

AU - Cymerman, Allen

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Beidleman, Beth A., Charles S. Fulco, Stephen R. Muza, Paul R. Rock, Janet E. Staab, Vincent A. Forte, Michael D. Brothers, and Allen Cymerman. Effect of six days of staging on physiological adjustments and acute mountain sickness during ascent to 4300 meters. High Alt. Med. Biol. 10:253-260, 2009.-This study determined the effectiveness of 6 days (d) of staging at 2200m on physiologic adjustments and acute mountain sickness (AMS) during rapid, high-risk ascent to 4300m. Eleven sea-level (SL) resident men (means±SD; 21±3yr; 78±13kg) completed resting measures of end-tidal CO2 (Petco2), arterial oxygen saturation (Sao2), heart rate (HR), and mean arterial pressure (MAP) at SL and within 1h of exposure to 4300m in a hypobaric chamber prior to 6d of staging at 2200m (preSTG) and on the summit of Pikes Peak following 6d of staging at 2200m (postSTG). Immediately following resting ventilation measures, all performed submaximal exercise (∼55% of altitude-specific maximal oxygen uptake) for ∼2h on a bicycle ergometer to induce higher levels of AMS. AMS-C, calculated from the Environmental Symptoms Questionnaire, was measured following 4h and 8h of exposure at preSTG and postSTG, and the mean was calculated. Resting Petco 2 (mmHg) was unchanged from SL (39.8±2.6) to preSTG (39.3±3.0), but decreased (p<0.05) from preSTG to postSTG (32.8±2.6). Resting Sao2 (%) decreased (p<0.05) from SL (97±2) to preSTG (80±4) and increased (p<0.05) from preSTG to postSTG (83±3). Resting HR (bpm) and MAP (mmHg) did not change in any of the test conditions. The incidence and severity of AMS-C decreased (p<0.05) from preSTG (91±30%; 1.05±0.56) to postSTG (45±53%; 0.59±0.43), respectively. These results suggest that modest physiologic adjustments induced by staging for 6d at 2200m reduced the incidence and severity of AMS during rapid, high-risk ascent to 4300m.

AB - Beidleman, Beth A., Charles S. Fulco, Stephen R. Muza, Paul R. Rock, Janet E. Staab, Vincent A. Forte, Michael D. Brothers, and Allen Cymerman. Effect of six days of staging on physiological adjustments and acute mountain sickness during ascent to 4300 meters. High Alt. Med. Biol. 10:253-260, 2009.-This study determined the effectiveness of 6 days (d) of staging at 2200m on physiologic adjustments and acute mountain sickness (AMS) during rapid, high-risk ascent to 4300m. Eleven sea-level (SL) resident men (means±SD; 21±3yr; 78±13kg) completed resting measures of end-tidal CO2 (Petco2), arterial oxygen saturation (Sao2), heart rate (HR), and mean arterial pressure (MAP) at SL and within 1h of exposure to 4300m in a hypobaric chamber prior to 6d of staging at 2200m (preSTG) and on the summit of Pikes Peak following 6d of staging at 2200m (postSTG). Immediately following resting ventilation measures, all performed submaximal exercise (∼55% of altitude-specific maximal oxygen uptake) for ∼2h on a bicycle ergometer to induce higher levels of AMS. AMS-C, calculated from the Environmental Symptoms Questionnaire, was measured following 4h and 8h of exposure at preSTG and postSTG, and the mean was calculated. Resting Petco 2 (mmHg) was unchanged from SL (39.8±2.6) to preSTG (39.3±3.0), but decreased (p<0.05) from preSTG to postSTG (32.8±2.6). Resting Sao2 (%) decreased (p<0.05) from SL (97±2) to preSTG (80±4) and increased (p<0.05) from preSTG to postSTG (83±3). Resting HR (bpm) and MAP (mmHg) did not change in any of the test conditions. The incidence and severity of AMS-C decreased (p<0.05) from preSTG (91±30%; 1.05±0.56) to postSTG (45±53%; 0.59±0.43), respectively. These results suggest that modest physiologic adjustments induced by staging for 6d at 2200m reduced the incidence and severity of AMS during rapid, high-risk ascent to 4300m.

KW - Arterial oxygen saturation

KW - Heart rate

KW - Hypobaric hypoxia

KW - Mean arterial pressure

KW - Resting ventilation

UR - http://www.scopus.com/inward/record.url?scp=70349514806&partnerID=8YFLogxK

U2 - 10.1089/ham.2009.1004

DO - 10.1089/ham.2009.1004

M3 - Article

C2 - 19775215

AN - SCOPUS:70349514806

VL - 10

SP - 253

EP - 260

JO - High Altitude Medicine and Biology

JF - High Altitude Medicine and Biology

SN - 1527-0297

IS - 3

ER -